Artelon

Artelon is a medical technology company that specializes in synthetic materials for orthopedic soft tissue reconstruction. Founded in 2014 by orthopedic surgeon Lars Peterson, M.D., Ph.D., the company focuses on restoring joint stability and kinematics through innovative ligament and tendon products. Artelon's proprietary polymeric bio-textile technology mimics the natural properties of healing ligament tissue, supporting soft tissue repair and promoting tissue regeneration over a period of five to six years. The product portfolio includes the Flexband® SOLO and Flexband MULTI, which are used in tendon repair surgeries across various applications, such as rotator cuff and Achilles tendon repairs. These products enhance surgical outcomes by reinforcing soft tissue and are typically used alongside sutures or suture anchors. With over 60,000 implantations worldwide, Artelon has established a strong clinical presence, particularly in the U.S. ankle instability market. In July 2024, Artelon was acquired by Stryker, integrating its innovative solutions into Stryker’s Trauma & Extremities division and enhancing offerings in soft tissue fixation and sports medicine.

• Employees 14
• Founded 2013
• Annual Revenue $2860000
• Total Funding $20000000